Skip to main content

Table 1 Participants’ demographic and medical characteristics (N = 89)

From: Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study

 

M (SD)

n (%)

Age (years)

53.5 (11.5)

 

Marital status

 Married/Cohabitating

 

62 (69.7)

 Separated/Divorced

 

22 (24.7)

 Single

 

4 (4.5)

 Widowed

 

1 (1.1)

Education completed

 Primary school

 

3 (3.4)

 High school

 

17 (19.1)

 College

 

26 (29.2)

 University

 

42 (47.2)

 Other

 

1 (1.1)

Occupation

 Full time work

 

53 (59.6)

 Part-time work

 

7 (7.9)

 Sick leave

 

3 (3.4)

 Unemployed/looking for work

 

1 (1.1)

 Retired

 

22 (24.7)

 Unpaid family work

 

2 (2.2)

 Other

 

1 (1.1)

Family income

 $40 000 and less

 

8 (9.0)

 $40 001–60 000

 

14 (15.7)

 $60 001–80 000

 

17 (19.1)

 $80 001- 100 000

 

6 (6.7)

 $100 001- 120 000

 

17 (19.1)

 $120 001 and more

 

20 (22.5)

 I don’t know or refuse to answer

 

7 (7.9)

Number of months since the most recent cancer diagnosis

95.9 (78.5)

 

Number of months since the most recent preventive surgery

70.0 (53.9)

 

Genetic mutation*

 BRCA 1

 

43 (48.3)

 BRCA 2

 

48 (53.9)

Knowledge of the mutation at the time of cancer diagnosis

 Yes

 

16 (18.0)

 No

 

73 (82.0)

Preventive mastectomy

 Surgery performed

 

56 (62.9)

 Surgery considered and planned

 

2 (2.2)

 Surgery considered, but not yet planned

 

8 (9.0)

 Surgery not performed and not considered

 

23 (25.8)

Preventive mastectomy performed

 Unilateral

 

13 (23.2)

 Bilateral

 

43 (76.8)

Breast reconstruction

 Yes

 

51 (58.2)

 No

 

38 (41.8)

Time of reconstruction

 During mastectomy (immediate reconstruction)

 

37 (72.5)

 After mastectomy (delayed reconstruction)

 

14 (27.5)

Preventive salpingo-oophorectomy

 Surgery performed

 

67 (75.3)

 Surgery considered and planned

 

6 (6.7)

 Surgery considered, but not yet planned

 

10 (11.2)

 Surgery not performed and not considered

 

6 (6.7)

Number of first-degree relatives who have developed cancer

 0

 

20 (22.5)

 1

 

34 (38.2)

 2

 

17 (19.1)

 3 and more

 

18 (20.2)

Number of second-degree relatives who have developed cancer

 0

 

6 (6.7)

 1

 

12 (13.5)

 2

 

10 (11.2)

 3 and more

 

61 (68.6)

  1. *The sum of these percentages exceeds 100% because some patients (n = 2) had both mutations